Get my own profile
Public access
View all23 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Veronique PreatProfesseur, Université catholique de LouvainVerified email at uclouvain.be
Kiran Kumar ChereddyUniversite catholique de Louvain, Lonza BiologicsVerified email at lonza.com
Héloïse RagelleMassachusetts Institute of TechnologyVerified email at mit.edu
Anne des RieuxUniversité catholique de LouvainVerified email at uclouvain.be
Gregor SersaHead of Department, Department of Experimental Oncology, Institute of Oncology LjubljanaVerified email at onko-i.si
Pierre SonveauxUniversity of Louvain (UCL) Medical SchoolVerified email at uclouvain.be
Helena F. FlorindoProfessor, University of LisbonVerified email at ff.ul.pt
Maja CemazarDepartment of Experimental Oncology, Institute of Oncology LjubljanaVerified email at onko-i.si
Paolo Ettore PorporatoUniversity of TurinVerified email at unito.it
Julie VanackerUniversité catholique de LouvainVerified email at uclouvain.be
Olivier FeronUCLouvainVerified email at uclouvain.be
Van den Eynde BenoitDirector, Brussels Branch of the Ludwig Institute for Cancer Research; Professor of Immunology, Univ. catholique de Louvain, de Verified email at bru.licr.org
Camilla FogedProfessor of Vaccine Design and Delivery, University of CopenhagenVerified email at sund.ku.dk
Pascal Kienlen-CampardUniversité catholique de LouvainVerified email at uclouvain.be
Christine Dupont-GillainProfessor and researcher, physical chemistry of biointerfacesVerified email at uclouvain.be
Carina PeresPostdoctoral research fellow at CICS-UBIVerified email at fcsaude.ubi.pt
Takis AthanasopoulosDirector, Head of Transgene Delivery, Cell & Gene Therapy Discovery Research (CGTDR), PlatformVerified email at gsk.com
Julien VerraxUniversité catholique de Louvain